Washington University DIAN-TU-001
Back to Drug Development Trials
![]()
Drug Development Trials
About the Washington University DIAN-TU-001 trial
A Phase II/III Multicenter Randomised, Double-Blind, Placebo-Controlled Platform Trials of Potential Disease Modifying Therapies Utilising Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer’s disease.
